Panzyga IVIg Infusion Therapy

WHAT iS PANZYGA?

Panzyga is a biologic, intravenous immunoglobulin (IVIg) drug that is used to treat primary immunodeficiency (PI) disease in patients 2 years of age and older, chronic immune thrombocytopenic purpura (ITP) in adults, and chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

HOW DOES PANZYGA WORK?

Panzyga contains immunoglobulin G (IgG), the main type of antibody made by the immune system. It helps protect the health of people with PI by supplying their immune systems with IgG antibodies to help prevent infections. Panzyga can also help improve motor function in adults with CIDP. For adults with chronic ITP, Panzyga can raise platelet counts to help prevent bleeding.

HOW IS PANZYGA ADMINISTERED?

Panzyga infusions are administered intravenously through a vein in the arm. The first infusion takes the most time. Subsequent infusions may last about 3 hours.

Primary Immunodeficiency (PI)

One dose is given every 3 or 4 weeks.

Immune Thrombocytopenic Purpura (ITP) & Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Loading dose is 2 daily doses given on 2 consecutive days. Maintenance dose is once every 3 weeks, divided in 2 doses given over 2 consecutive days.

Click here to view the pharmaceutical website for Panzyga.

PANZYGA INFUSION PATIENT ASSISTANCE PROGRAM

• Pfizer PANZYGA Co-Pay Program

This product may be used to treat other conditions not listed. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions about whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.

If you’d like more information about the other treatment options we offer, please visit the IV infusions or biologic injections pages to learn more.